Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Omega Therapeutics, Inc./ EFFECT

SEC Filing · EFFECT

Omega Therapeutics, Inc.

SEC Filing

Filed Mar 25, 2025Accepted Mar 25, 2025, 8:15 PM EDTCIK 1850838Accession 9999999995-25-000753
View company →Permanent SEC source ↗
Share

Recent company filings

  1. 15-12G filingMar 31, 2025
  2. POS AM filingMar 21, 2025
  3. S-8 POS filingMar 21, 2025
  4. 25 filingMar 20, 2025
  5. SCHEDULE 13G/A - filed by FMR LLC regarding Omega Therapeutics, Inc.Mar 7, 2025

As-filed source

Primary evidence
As filedOpen full document ↗